Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds.
A stack of disposable diapers in the foreground with a mother and her baby in the background.
In June, the company announced a strategic partnership with Suzano S.A. to establish a global tissue and professional products company. This move is viewed as a way for Kimberly-Clark to sharpen its focus on higher-growth, higher-margin segments. By combining their strengths and infrastructure, the two companies aim to lower overall product delivery costs and provide both branded and private label solutions across various markets, ultimately benefiting both consumers and customers.
In the first quarter of 2025, Kimberly-Clark Corporation (NASDAQ:KMB) maintained a healthy cash position, generating $327 million in operating cash flow, while capital expenditures reached $204 million. The company remained committed to rewarding shareholders, returning $466 million through dividends and share repurchases. Quarterly revenue stood at $4.84 billion, reflecting a 6% decline compared to the same period the previous year.
Kimberly-Clark Corporation (NASDAQ:KMB) is a Dividend King with 53 consecutive years of dividend growth under its belt. The company offers a quarterly dividend of $1.26 per share and has a dividend yield of 3.97%, as of July 25.
Kimberly-Clark Corporation (NASDAQ:KMB) is known for offering a broad range of everyday household products, including diapers, tissues, and feminine care items. Its portfolio features several popular brands such as Huggies, Kleenex, and Cottonelle.
While we acknowledge the potential of KMB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 14 Stocks That Paid Special Dividends in 2025 and Dividend Champions vs Aristocrats: 12 Under-the-Radar Stocks to Buy
Disclosure: None.
